Skip to content

Real world study on etiology, treatment and prognosis of recurrent pregnancy loss

Real world study on etiology, treatment and prognosis of recurrent pregnancy loss

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041294
Enrollment
Unknown
Registered
2020-12-23
Start date
2021-01-20
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent pregnancy loss

Interventions

case series:Nil

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Women with two or more previous pregnancy losses; 2. Both husband and wife have no family genetic disease and normal chromosome karyotype 3. Normal analysis of male semen and without exual dysfunction; 4. Volunteer to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Taking other experimental drugs or participating in other clinical trials within 1 month prior to inclusion; 2. Clinicians do not think she is appropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
live birth rate;

Secondary

MeasureTime frame
Rate of successful pregnancy;pregnancy complication;

Countries

China

Contacts

Public ContactMu Fangxiang

The First Affiliated Hospital of Chongqing Medical University

ky12@163.com+86 15923344778

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026